| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| K Hermanse. Effects of cholecystokinin (CCK)-4, nonsulfated CCK-8, and sulfated CCK-8 on pancreatic somatostatin, insulin, and glucagon secretion in the dog: studies in vitro. Endocrinology. vol 114. issue 5. 1984-05-30. PMID:6143659. |
effects of cholecystokinin (cck)-4, nonsulfated cck-8, and sulfated cck-8 on pancreatic somatostatin, insulin, and glucagon secretion in the dog: studies in vitro. |
1984-05-30 |
2023-08-12 |
dog |
| Y Tanaka, Y Seino, M Ishida, K Yamaoka, H Yabuuchi, H Ishida, S Seino, Y Seino, H Imur. Effect of vitamin D3 on the pancreatic secretion of insulin and somatostatin. Acta endocrinologica. vol 105. issue 4. 1984-05-30. PMID:6144227. |
effect of vitamin d3 on the pancreatic secretion of insulin and somatostatin. |
1984-05-30 |
2023-08-12 |
rat |
| Y Tanaka, Y Seino, M Ishida, K Yamaoka, H Yabuuchi, H Ishida, S Seino, Y Seino, H Imur. Effect of vitamin D3 on the pancreatic secretion of insulin and somatostatin. Acta endocrinologica. vol 105. issue 4. 1984-05-30. PMID:6144227. |
to clarify the role of vitamin d in the regulation of the endocrine pancreas, we have studied insulin and somatostatin secretion in vitamin d deficient rats (reared on a vitamin d deficient diet), d-replete rats (reared on a vitamin d deficient diet and given 160 iu of vitamin d3 sc twice a week) and control rats (reared on laboratory chow), using the isolated perfused rat pancreas. |
1984-05-30 |
2023-08-12 |
rat |
| P P Gerber, E R Trimble, L Herberg, A E Renol. Glucose-induced somatostatin secretion by the rat pancreas is not potentiated by glucose. Acta endocrinologica. vol 105. issue 4. 1984-05-30. PMID:6144228. |
the effect of previous exposure to glucose on subsequent glucose-stimulated insulin and somatostatin secretion has been investigated using the isolated perfused rat pancreas. |
1984-05-30 |
2023-08-12 |
rat |
| P P Gerber, E R Trimble, L Herberg, A E Renol. Glucose-induced somatostatin secretion by the rat pancreas is not potentiated by glucose. Acta endocrinologica. vol 105. issue 4. 1984-05-30. PMID:6144228. |
since exogenous insulin is known to inhibit glucose-induced somatostatin secretion, it seemed possible that lack of visible potentiation of glucose-induced somatostatin secretion by glucose could have been due to partial d cell inhibition by simultaneously augmented insulin secretion during the second glucose stimulation. |
1984-05-30 |
2023-08-12 |
rat |
| P P Gerber, E R Trimble, L Herberg, A E Renol. Glucose-induced somatostatin secretion by the rat pancreas is not potentiated by glucose. Acta endocrinologica. vol 105. issue 4. 1984-05-30. PMID:6144228. |
in an attempt to exclude such an interaction between b and d cells, somatostatin secretion was also studied in the pancreases of spontaneously diabetic, wistar (bb) rats (these animals are insulin deficient and are maintained by daily injections of insulin). |
1984-05-30 |
2023-08-12 |
rat |
| P P Gerber, E R Trimble, L Herberg, A E Renol. Glucose-induced somatostatin secretion by the rat pancreas is not potentiated by glucose. Acta endocrinologica. vol 105. issue 4. 1984-05-30. PMID:6144228. |
however, even though insulin secretion was not detectable from these pancreases, glucose potentiation of glucose-induced somatostatin secretion did not occur. |
1984-05-30 |
2023-08-12 |
rat |
| P P Gerber, E R Trimble, L Herberg, A E Renol. Glucose-induced somatostatin secretion by the rat pancreas is not potentiated by glucose. Acta endocrinologica. vol 105. issue 4. 1984-05-30. PMID:6144228. |
although the pancreatic b and d cells are known to respond in a similar manner to many secretagogues the present results show that glucose potentiation of glucose-stimulated somatostatin secretion is not found under circumstances where potentiation of insulin secretion does occur. |
1984-05-30 |
2023-08-12 |
rat |
| P P Gerber, E R Trimble, L Herberg, A E Renol. Glucose-induced somatostatin secretion by the rat pancreas is not potentiated by glucose. Acta endocrinologica. vol 105. issue 4. 1984-05-30. PMID:6144228. |
in addition, the absence of potentiated somatostatin secretion could not be attributed to partial inhibition of the d cell by insulin. |
1984-05-30 |
2023-08-12 |
rat |
| G Ribes, E R Trimble, J P Blayac, C B Wollheim, M M Loubatières-Marian. In vivo stimulation of pancreatic hormone secretion by norepinephrine infusion in the dog. The American journal of physiology. vol 246. issue 4 Pt 1. 1984-05-30. PMID:6144271. |
norepinephrine stimulated insulin, somatostatin, and glucagon secretion without significant changes in either blood glucose concentration or pancreaticoduodenal venous blood flow. |
1984-05-30 |
2023-08-12 |
dog |
| A Stenberg, S Gustavsson, G Lundqvist, L Thoré. Effect of surgical trauma on plasma insulin and somatostatin in response to glucose. Acta chirurgica Scandinavica. vol 150. issue 2. 1984-05-30. PMID:6372345. |
effect of surgical trauma on plasma insulin and somatostatin in response to glucose. |
1984-05-30 |
2023-08-12 |
human |
| A Stenberg, S Gustavsson, G Lundqvist, L Thoré. Effect of surgical trauma on plasma insulin and somatostatin in response to glucose. Acta chirurgica Scandinavica. vol 150. issue 2. 1984-05-30. PMID:6372345. |
the role of somatostatin for the suppression of insulin release in the early post-traumatic phase was investigated by measurement of somatostatin-like immunoreactivity in plasma during an intravenous glucose tolerance test. |
1984-05-30 |
2023-08-12 |
human |
| A Stenberg, S Gustavsson, G Lundqvist, L Thoré. Effect of surgical trauma on plasma insulin and somatostatin in response to glucose. Acta chirurgica Scandinavica. vol 150. issue 2. 1984-05-30. PMID:6372345. |
the present data with hormone determinations in peripheral blood does not support the hypothesis that somatostatin, a potent inhibitor of insulin release, mediates the insulin suppression in the early trauma phase. |
1984-05-30 |
2023-08-12 |
human |
| V Schusdziarra, A Holland, V Maier, E F Pfeiffe. Effect of naloxone on pancreatic and gastric endocrine function in response to carbohydrate and fat-rich test meals. Peptides. vol 5. issue 1. 1984-05-21. PMID:6143305. |
these data raise the possibility that endogenous opiates participate in the regulation of postprandial insulin, glucagon, somatostatin and pancreatic polypeptide release not only in certain disease states as demonstrated recently for insulin secretion in type ii diabetes mellitus but endogenous opiates may also be of importance under physiological conditions. |
1984-05-21 |
2023-08-12 |
human |
| P M Radosevich, P E Williams, J R McRae, W W Lacy, D N Orth, N N Abumra. Beta-endorphin inhibits glucose production in the conscious dog. The Journal of clinical investigation. vol 73. issue 4. 1984-05-21. PMID:6323537. |
the effect of human beta-endorphin (h beta e) infusion (0.2 mg/h) on glucose homeostasis was studied in 10 conscious overnight fasted dogs in which endocrine pancreatic function was fixed at basal levels with somatostatin plus intraportal replacement of basal insulin and glucagon. |
1984-05-21 |
2023-08-12 |
human |
| D F Trent, M A Schwalke, G C Wei. Pancreatic and gut hormones during fasting: insulin, glucagon, and somatostatin. Hormone research. vol 19. issue 2. 1984-05-17. PMID:6142854. |
pancreatic and gut hormones during fasting: insulin, glucagon, and somatostatin. |
1984-05-17 |
2023-08-12 |
rat |
| D F Trent, M A Schwalke, G C Wei. Pancreatic and gut hormones during fasting: insulin, glucagon, and somatostatin. Hormone research. vol 19. issue 2. 1984-05-17. PMID:6142854. |
when adult male rats were fasted for 24 or 72 h there was no change in the pancreatic content of insulin or glucagon, but the somatostatin content increased at 72 h. this contrasts with earlier reports of reduced pancreatic somatostatin after fasting. |
1984-05-17 |
2023-08-12 |
rat |
| D F Trent, M A Schwalke, G C Wei. Pancreatic and gut hormones during fasting: insulin, glucagon, and somatostatin. Hormone research. vol 19. issue 2. 1984-05-17. PMID:6142854. |
insulin secretion from the perfused pancreata of 72-hour-fasted rats was markedly reduced, but glucagon and somatostatin secretion was indistinguishable from that of fed controls. |
1984-05-17 |
2023-08-12 |
rat |
| D F Trent, M A Schwalke, G C Wei. Pancreatic and gut hormones during fasting: insulin, glucagon, and somatostatin. Hormone research. vol 19. issue 2. 1984-05-17. PMID:6142854. |
these results indicate that in spite of the marked alterations of nutrient metabolism and insulin secretion which occur during fasting, the pancreatic content of insulin, glucagon and somatostatin and the gut concentration of somatostatin are well maintained. |
1984-05-17 |
2023-08-12 |
rat |
| D F Veber, R Saperstein, R F Nutt, R M Freidinger, S F Brady, P Curley, D S Perlow, W J Paleveda, C D Colton, A G Zacche. A super active cyclic hexapeptide analog of somatostatin. Life sciences. vol 34. issue 14. 1984-05-17. PMID:6143233. |
we now report structure-activity studies which optimize the potency of this cyclic hexapeptide series with the synthesis of cyclo (n-me-ala-tyr-d-trp-lys-val-phe), ii, which is 50-100 times more potent than somatostatin for the inhibition of insulin, glucagon and growth hormone release. |
1984-05-17 |
2023-08-12 |
Not clear |